ContraFect Corp. (CFRXQ) Financials

CFRXQ Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 9.1 million 14.9 million
June 30, 2023 19.3 million 20.4 million
March 31, 2023 20.6 million 23.7 million
Dec. 31, 2022 20.7 million 32.5 million

CFRXQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -8.7 million 709000
June 30, 2023 -8.2 million 795000
March 31, 2023 -8.8 million 932000
Dec. 31, 2022 -10.0 million 983000

CFRXQ Net Income

No data available :(

CFRXQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 5.4 million - 2.6 million
June 30, 2023 14.4 million - 2.7 million
March 31, 2023 13.9 million - 2.8 million
Dec. 31, 2022 13.7 million - 2.9 million

CFRXQ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 10.7 million
June 30, 2023 3.9 million
March 31, 2023 2.0 million
Dec. 31, 2022 609590

CFRXQ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 3.9 million 2.8 million -
June 30, 2023 15000 4.9 million 3.1 million -
March 31, 2023 5000 5.3 million 3.5 million -
Dec. 31, 2022 43000 4.4 million 2.2 million -39000

CFRXQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 39000
June 30, 2023 - 41000
March 31, 2023 - 40000
Dec. 31, 2022 - 39000

CFRXQ

Price: $0

52 week price:
0.00
0.00

Earnings Per Share: -1.50 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 107

Links: